UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.09 +0.09 (+0.11%) GOLD FUTURES
2,314.00 +3.00 (+0.13%) DOW
38,266.76 +363.47 (+0.96%) Bitcoin GBP
47,166.14 +825.34 (+1.78%)
Roche Holding AG (ROG.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
At close: 05:30PM CEST
| Previous close | 220.60 |
| Open | 220.20 |
| Bid | 214.00 x 0 |
| Ask | 214.10 x 0 |
| Day's range | 213.60 - 222.80 |
| 52-week range | 213.60 - 293.55 |
| Volume | |
| Avg. volume | 1,471,749 |
| Market cap | 172.781B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 14.95 |
| EPS (TTM) | 14.32 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 9.60 (4.35%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 273.94 |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.